-
2024-516418-39-00
5
2025-07-09
Multiple Myeloma
-
2024-519282-22-00
5
2025-07-09
Chronic Hepatitis D Virus (HDV) Infection
-
2024-517247-31-00
5
2025-07-07
Newly Diagnosed Higher Risk Myelodysplastic Syndrome
-
2023-504831-42-00
5
2025-06-27
patient with colorectal cancer with hepatic metastasis
-
2024-514596-18-00
9
2025-06-20
Difficult to treat rheumatoid arthritis
-
2024-513122-27-00
5
2025-06-10
Unresectable, Locally Advanced or Metastatic HER2 positive Gastric or
-
2024-512302-25-00
5
2025-06-06
Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
-
2024-517457-27-00
5
2025-06-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2023-509391-42-00
11
2025-06-02
Chron's Disease
-
2024-519116-14-00
4
2025-05-27
Asthma
-
2023-504511-32-00
5
2025-05-24
Any patients ≥18 years old, eligible for transfemoral TAVI with covera
-
2024-513959-33-00
4
2025-05-13
Asthma
-
2024-516605-23-00
5
2025-05-12
relapsed/refractory nodal T cell lymphoma with T follicular helper (TF
-
2023-510155-37-00
5
2025-05-08
Hypomethylating agent (HMA) naive myelodysplastic syndromes
Myelodyspl
-
2024-515162-13-00
5
2025-04-29
Eosinophilic Asthma
-
2023-506512-40-00
5
2025-04-16
Acute Kidney Injury
-
2023-506601-19-00
6
2025-04-15
transplantation
-
2024-516791-15-00
4
2025-04-08
Relapsed/Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)
-
2022-501489-24-00
5
2025-03-28
First-line treatment of adult subjects with high-risk large B-cell lym
-
2023-504086-23-00
5
2025-03-27
Subjects with PBC with a non-optimal response to UDCA.
-
2024-514804-14-00
6
2025-03-26
Liver transplantation
-
2023-508201-25-00
4
2025-03-12
Hepatocellular carcinoma
-
2023-508798-94-00
5
2025-02-11
Heart failure
-
2022-502352-31-00
5
2025-02-10
Colorectal Cancer (CRC)